banner
Reference Listed Drugs
Elunate 1mg 5mg Fruquintinib Capsules Reference Listed Drug

Elunate 1mg 5mg Fruquintinib Capsules Reference Listed Drug

Elunate monotherapy is indicated for patients with metastatic colorectal cancer (mCRC) who have previously received fluorouracil, oxaliplatin, and irinotecan based chemotherapy, and who have previously received or are not eligible for anti-vascular endothelial growth factor (VEGF) or anti-epidermal growth factor receptor (EGFR) therapy (RAS wild type). For R&D purposes only.

Product Details

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

 

Generic name Fruquintinib Capsules
Trade name Elunate
Specification 1mg 5mg
Main ingredients Fruquintinib
Appearance The contents of this product are white to white powder.
Manufacturer

Hutchison Whampoa Pharmaceutical (Suzhou) Co., Ltd

和记黄埔医药(苏州)有限公司

 

 

 

 

Indications:

Elunate monotherapy is indicated for patients with metastatic colorectal cancer (mCRC) who have previously received fluorouracil, oxaliplatin, and irinotecan based chemotherapy, and who have previously received or are not eligible for anti-vascular endothelial growth factor (VEGF) or anti-epidermal growth factor receptor (EGFR) therapy (RAS wild type).

 

 

 

elunate

 

 

 

 

 

For more details,pls contact Janney:

Email: tosun-global@upharm.cn

Wechat/Whatsapp:(+86)18922120575

 

 

 

Hot Tags: Elunate 1mg 5mg Fruquintinib Capsules Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Esomeprazole Magnesium Enteric Coated Capsules, Acarbose Tablets, Bimatoprost Ophthalmic, Adefovir Dipivoxil Tablets, Alfacalcidol Soft Capsules, Argatroban Injection

Send Inquiry
Verification Code: